There is sufficient evidence indicating that this pathway is over-activated in various types of cancer, including HCC that is usually related to overexpression and over-activation of ERK1/2 and results in high proliferation, growth, and invasion of tumor cells. This evidence concerns the gene MAPK3 and cancer.